Considering that CD24 regulates miRNA expression and multiple miRNAs regulate MET,22 it is plausible that CD24 induces the expression of MET by controlling miRNA activity, thus conferring stem‐like properties to ovarian cancer. The gene discussed is CD24; the disease is ovarian carcinoma.